Find latest Myeloma videos · 600+ videos
ecancer
T

ASCO® 2024 Insights: "IMROZ - A Ph3 Study of Isatuximab + VRd vs. VRd for Transplant-Ineligible NDMM"

By ecancer FEATURING Thierry Facon
By ecancer FEATURING Thierry Facon
113 views
June 24, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

15:58
Amgen Hematology

Insights on Proteasome Inhibitor Combinations at First Relapse in Mu…

Feat. M. Levy

Related Videos

21:06

ASH 2024 Summary: Myeloma Highlights and Impact on Practice

2024 ASH Annual Meeting Insights Hub

H. Hashmi

1.4K views
15:00

FDA Approval of Isatuximab in 1L MM: Perspectives for Practice

Dana-Farber Cancer Institute

P. Richardson

1.0K views
28:15

ASH 2024 Review: Key Multiple Myeloma Abstracts

Cleveland Clinic Taussig Cancer Institute

N. Callander

490 views
19:28

ASH 2024 Summary: Multiple Myeloma Highlights and Clinical Implicati…

2024 ASH Annual Meeting Insights Hub

S. Al Hadidi

487 views
04:55

ASH 2024 Insights: Dara vs. Len Maintenance in NDMM - Interim Result…

2024 ASH Annual Meeting Insights Hub

U. Shah

255 views
21:05

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

4.9K views
15:35

Multiple Myeloma: Not as Simple as "CRAB" Anymore

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

R. Banerjee

801 views
09:15

ASH 2024 Summary: Transplant in Myeloma - Key Factors in Decision-Ma…

2024 ASH Annual Meeting Insights Hub

A. Perrot

184 views
19:38

Fast Five Key Updates in Malignant Heme: Pearls From a Pharmacist

Total Health

S. Medeiros

300 views
06:06

The Future of NDMM Treatment: Ongoing Trials and Key ASH 2024 Oral A…

University of Miami Sylvester Comprehensive Cancer Center

O. Landgren

102 views
17:52

2024 Updates on Emerging & Current Treatment of Multiple Myeloma

Indy Hematology Review

K. Anderson

1.3K views
35:27

Advances in Multiple Myeloma 2024: From Bench to Bedside

Dana-Farber Cancer Institute

K. Anderson

732 views
30:09

Expert Roundtable: Future Directions in Managing NDMM - MRD, CAR-T, …

MyCancerHaven

R. Vij, P. Kapoor, M. Alsina, S. Mailankody, A. Nooka, S. Tuchman

128 views
24:35

ASCO® 2024 Summary: "The Best of Myeloma - Review of the Top 5 Abstr…

2024 ASCO® Annual Meeting Insights Hub

H. Hashmi

661 views
28:46

Updates on Managing NDMM in 2024

Louisville Hematology Highlights

S. Usmani

125 views
21:41

Multiple Myeloma: Hot Topics in 2024

Yale Cancer Center

S. Browning

232 views
10:57

Indefinite Treatment of Multiple Myeloma: Strategies for Frail Patie…

Shaji Kumar

130 views
13:32

ASH 2024 Insights: Analyses of MRD Negativity Dynamics in the Phase …

2024 ASH Annual Meeting Insights Hub

R. Orlowski

128 views
12:35

Summary of Data for Transplant-Ineligible NDMM: Proposed SoC Approach

Moffitt Cancer Center

R. Baz

109 views
22:33

Treatment Strategies for R/R MM After Frontline Anti-CD38 Therapy

Integrity CE

S. Usmani, J. Hillengass

252 views
AUTOPLAY